Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
federica.mazzuca@uniroma1.it
Federica Mazzuca
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
federica.mazzuca@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Diagnostic and Therapeutic Management of Primary Orbital Neuroendocrine Tumors (NETs): Systematic Literature Review and Clinical Case Presentation
BIOMEDICINES
2024
Is CT Radiomics Superior to Morphological Evaluation for pN0 Characterization? A Pilot Study in Colon Cancer
CANCERS
2024
Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review
HEALTHCARE
2024
Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report
FRONTIERS IN ONCOLOGY
2024
529P Evaluating metastatic disease sites as a prognostic marker in patients receiving sequential treatment with regorafenib and trifluridine/tipiracil for refractory colorectal cancer: Survival outcomes from the multicenter retrospective “ReTrITA” study
ANNALS OF ONCOLOGY
2024
The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
2023
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study
CURRENT ONCOLOGY
2023
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
FRONTIERS IN ONCOLOGY
2023
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis
CANCERS
2023
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study
CANCER MANAGEMENT AND RESEARCH
2022
Tumor regression grade (TRG) for gastric cancer and radiological methods on predicting response to perioperative chemotherapy. a narrative review
DIGESTIVE MEDICINE RESEARCH
2022
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach
RADIOLOGY AND ONCOLOGY
2022
Comparative Analysis of Regorafenib and Trifluridine/Tipiracil in Later-Line Refractory Metastatic Colorectal Cancer: A Real-Life Multicenter Retrospective Study
TUMORI
2022
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis
CANCER MANAGEMENT AND RESEARCH
2022
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients: The new drug-pin® system comprehensive approach
PHARMACEUTICALS
2021
CT based radiomic approach on first line pembrolizumab in lung cancer
SCIENTIFIC REPORTS
2021
Hepatocellular carcinoma drug-eluting bead transarterial chemoembolization (Deb-tace): outcome analysis using a model based on pre-treatment ct texture features
DIAGNOSTICS
2021
The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
FRONTIERS IN IMMUNOLOGY
2021
How technology can help in oncologic patient management during COVID-19 outbreak
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2020
1
2
3
4
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma